|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Proteolytic degradation of extracellular matrix is thought to
play an important role both in emphysema and in tissue development and repair. Retinoic acid has been suggested to
modify tissue injury, and in an animal model of emphysema
may induce alveolar repair. Since cytokines can induce matrix
metalloproteinase (MMP) production in fibroblasts and neutrophil elastase (NE) can activate MMPs, we hypothesized
that retinoic acid could attenuate collagen degradation by
modifying MMP production and activation. To evaluate this,
human lung fibroblasts were cast into native type I collagen gels and floated in medium containing cytomix (TNF-
, IL-1
,
and IFN-
) alone or in combination with NE in the presence
and absence of retinoic acid (1 µM). After 5 d, cytomix with
elastase induced significant degradation of the collagen gels
assessed by quantifying total hydroxyproline (41.6 ± 1.6 µg
versus 3.3 ± 1.5 µg, P < 0.01). Retinoic acid significantly inhibited this degradation (23.3 ± 1.5 µg versus 3.3 ± 1.5 µg, P < 0.01). Gelatin zymography and Western blot revealed that
MMP-1, MMP-3, and MMP-9 were induced by cytomix and
that co-exposure to NE resulted in increased production of activated forms of these enzymes. Retinoic acid attenuated the
induction and activation of MMP-1 and MMP-3. The current
study, therefore, suggests that in addition to stimulating anabolic effects, retinoic acid may modulate proteolytic processes
thought to contribute to tissue destruction in emphysema.
| |
Introduction |
|---|
|
|
|---|
Emphysema, a disease characterized by destruction of alveolar walls, has generally been accepted as an irreversible lesion (1, 2). The observation that retinoic acid can partially reverse emphysema in an animal model (3), however, has challenged this concept and engendered considerable excitement for the potential development of novel therapeutic approaches in emphysema. Retinoids are believed to play an important role in regulating the alveolarization process during lung development (4, 5). This has led to the concept that neoalveolarization induced by retinoic acid following the development of emphysema may be, in part, a recapitulation of the alveolarization process. Other, non-exclusive mechanisms for retinoid activity in emphysema may also be possible.
The observation that individuals with homozygous
1
protease inhibitor deficiency are unusually susceptible to
the development of emphysema led to the "protease-anti-protease" hypothesis of emphysema (1, 6). In this concept, proteolytic activity in excess of anti-proteolytic defenses can lead to the development of emphysema (1). It is
now believed that other destructive processes, including
oxidants (9, 10) and potentially toxic peptides such as defensins, may also play a role in tissue destruction leading
to emphysema. In its expanded form, the protease-anti-protease hypothesis remains the most widely accepted
concept for the development of emphysema (11). Agents
that inhibit these destructive processes have the potential
for altering the development of this disease.
Retinoids are capable of regulating a large number of metabolic processes (5, 12), including matrix metalloproteinases (MMPs). It is reasonable to hypothesize, therefore, that retinoids might be able to modulate extracellular matrix turnover and, by such a mechanism, could regulate the tissue remodeling believed to play an important role in emphysema. The current study, therefore, was designed to evaluate the ability of retinoids to modulate fibroblast-driven extracellular matrix degradation. The in vitro system in which fibroblasts are cultured in a three-dimensional matrix composed of type I collagen was used as a model system to assess this hypothesis.
| |
Materials and Methods |
|---|
|
|
|---|
Type I collagen was extracted from rat-tail tendons (RTTC) by a
previously published method (16, 17). Briefly, tendons were excised from rat tails, and the tendon sheath and other connective tissues were removed carefully. After repeated washing with tris-buffered saline (TBS, 0.9% NaCl, 10 mM Tris, pH 7.5) and 95%
ethanol, type I collagen was extracted in 6 mM hydrochloric acid at
4°C for 24 h. Protein concentration was determined by weighing a
lyophilized aliquot from each lot of collagen solution. Sodium
dodecyl sulfate polyacrylamide gel electrophoresis routinely demonstrated no detectable proteins other than type I collagen. Human neutrophil elastase (NE) was purchased from Elastin Products Company (Owensville, MO). All-trans retinoic acid (RA) and
1-antitrypsin (
1-PI) was purchased from Sigma (St. Louis, MO).
Human recombinant tumor necrosis factor (TNF)-
, human recombinant interleukin (IL)-1
, and human recombinant interferon
(IFN)-
were purchased from R&D Systems (Minneapolis, MN).
Tissue culture supplements and media were purchased from
GIBCO (Life Technologies, Grand Island, NY). Fetal calf serum
(FCS) was purchased from Biofluid (Rockville, MD).
Cell Cultures
Human fetal lung fibroblasts (HFL-1) were obtained from the American Type Culture Collection (Rockville, MD). The cells were cultured in 100-mm tissue culture dishes (Falcon, Becton Dickinson Labware, Lincoln Park, NJ) with Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% FCS, 50 U/ml penicillin, 50 µg/ml streptomycin, and 0.25 µg/ml fungizone. The fibroblasts were passaged every 3-5 d. Subconfluent fibroblasts were trypsinized (trypsin-EDTA; 0.05% trypsin, 0.53 mM EDTA-4 Na) and used for collagen gel culture. Fibroblasts used in these experiments were between cell passages 14 and 19.
NE was dissolved in phosphate-buffered saline (PBS) to a
stock solution of 1 mg/ml. TNF-
, IL-1
, and IFN-
were dissolved in PBS to a stock solution of 1 µg/ml. RA was dissolved in
dimethyl sulfoxide (DMSO) to a stock solution of 1 mM.
Preparation of Collagen Gels
Collagen gels were prepared as described previously (17). Briefly,
the appropriate amount of RTTC was mixed with distilled water,
4× concentrated DMEM, and cell suspension so that the final mixture resulted in 0.75 mg/ml of collagen, 4.5 × 105 cells/ml, and
a physiologic ionic strength. Fibroblasts were routinely added last
to minimize damage during the preparation of collagen gels. One-half milliliter of the mixture was cast into each well of 24-well tissue culture plates (Falcon, Franklin Lakes, NJ). Gelation occurred
in about 20 min at room temperature, after which the gels were
released and transferred to 60-mm tissue culture dishes containing 5 ml of serum-free DMEM and stored at 37°C with 5% CO2
for 4-5 d. To demonstrate the effects of cytokines and elastase on
collagen gel contraction and collagen degradation, cytomix (18)
(TNF-
10 ng/ml, IL- 1
5 ng/ml, and IFN-
10 ng/ml), NE, or the
combination of NE with cytokines was added to culture media.
To investigate the effect of RA on gel contraction and collagen
degradation, RA (1 µM) was added into the media containing NE, cytomix, or the combination. Gel area was measured daily
using an image analysis system (Optomax, Hollis, NH).
Hydroxyproline Assay
The amount of hydroxyproline, which is directly proportional to type I collagen content in the gels, was measured by spectrophotometric determination (19, 20). Briefly, the media surrounding gels was completely removed, and the gels were transferred to glass tubes (KIMAX, Fisher Scientific, St. Louis, MO) with 2 ml of 6N HCl. Oxygen was removed by ventilating with pure nitrogen for 30 s. The gels were then hydrolyzed at 110°C for 12 h. The samples were dried with a vacuum centrifuge, then dissolved in dH2O. Hydroxyproline in the samples reacted with oxidant (1.4% Chloramine T in acetate/citric acid buffer, Sigma) and Ehrlich's reagent (0.4% p-Dimenthylamino-benzaldehyde [Sigma], in 60% perchloric acid, Fisher Chemical) at 65°C for 25 min, and absorbance was measured at 550 nm (Ultrospec 2000, Pharmacia Biotech, Piscataway, NH).
Gelatinase Activity Assay
To determine the presence of active gelatinase, gelatin zymography was prepared. Conditioned media were concentrated 10-fold by lyophilization, followed by solution in distilled water. Gelatin zymography was performed by a modification of previously published procedures (21, 22). The samples were dissolved in 2-fold electrophoresis sample buffer, and heated for 5 min at 95°C. Thirty microliters of each sample were then loaded in each lane, and electrophoresis was performed at 45 mV per gel. After this, the gels were soaked with 2.5% (v/v) Triton-X 100 gently shaking at 20°C for 30 min, then incubated in the metalloproteinase buffer (0.06 M Tris-HCL, pH 7.5, containing 5 mM CaCL2 and 1 µM ZnCL) for 18 h at 37°C. The gels were stained with 0.4% (w/v) Coomassie blue and rapidly destained with 30% (v/v) methanol, 10% (v/v) acetic acid. The gels were dried between dialysis membranes (cellophane sheets; Pharmacia Biotech, San Francisco, CA).
Immunoblot Analysis of Metalloproteinases
To further identify the MMPs produced, immunoblots were performed. Supernatant media from three-dimensional cultures were precipitated with ethanol, resuspended in an equal volume dH2O and 2× sample buffer (0.5 M Tris-HCl, pH 6.8, 10% sodium dodecyl sulfate [SDS], 0.1% bromphenol blue, 20% glycerol). After heating for 3 min at 95°C, 30 µl of each sample was loaded into each well, and electrophoresis was performed with mini-protein 3 cells (Bio-Rad, Hercules, CA). The proteins were transferred to polyvinyl difluoride (PVDF) membranes (Bio-Rad) in electroblotting buffer (20 mM tris, pH 8.0, 150 mM glycine, 20% MeOH) at 20 V for 35 min with semi-dry electrophoretic transfer cell (Bio-Rad). The blots were blocked in 5% nonfat milk in PBS-Tween at room temperature for 1 h and then exposed to primary antibodies (mouse anti-human MMP-1, MMP-3, TIMP-1, and TIMP-2; Calbiochem, Cambridge, MA) for 1 h. Target protein was subsequently detected using rabbit anti-mouse IgG horseradish peroxidase (Rockland, Gilbertsville, PA) in conjunction with an enhanced chemiluminescence detection system (ECL; Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, England).
NE Activity Assay
To investigate the effect of RA on functional NE, NE activity
was quantified (23). NE (40 nM), RA (1 µM), or cytomix alone or
in various combinations were added to the media in which collagen gels with or without fibroblasts were floated.
1-Protease
inhibitor (
1-PI) was used as a control elastase inhibitor (100 nM).
The conditioned media were harvested at 2, 12, 24, and 48 h of
incubation. Elastase activity was measured using a synthetic
substrate, methoxy-succinyl-alanyl-prolyl-valyl-p-nitroanilide (Calbiochem-Novabiochem Co., La Jolla, CA). The supernatants
(100 µl) were incubated with 200 µl of 0.2 M substrate in 0.1 M
HEPES, 0.5 M NaCl, and 10% DMSO at pH 7.5. After incubation for 24 h, absorbance of the product, p-nitroanilide, was measured at 414 nm. Purified human NE was used as a standard, and
the elastase activity was expressed as ng/ml.
Statistical Evaluation
Results are expressed as the means of three determinations ± SEM except as described otherwise. The gel contraction assay, hydroxyproline measurement, and zymograms were confirmed by repeating experiments on separate occasions at least three times. The data shown in each figure were taken from single, representative experiments except as described. Grouped data were evaluated by analysis of variance (ANOVA), followed by Bonferroni correction. Differences between two groups were analyzed by unpaired Student's t test and comparisons were considered statistically significant if P < 0.05.
| |
Results |
|---|
|
|
|---|
Effect of RA on Fibroblast-Mediated Collagen Gel Contraction
By Day 5, NE augmented and cytomix inhibited fibroblast-mediated collagen gel contraction, and NE plus cytomix together further enhanced the gel contraction compared with elastase alone. RA resulted in a significant inhibition of the synergistic augmentation of contraction observed when elastase and cytomix were added together. In the absence of RA, on average, the two agents together resulted in gel contraction to 2.5 ± 0.3% of original size, while in the presence of RA, gels contracted to 15.1 ± 2.1% of original size (P < 0.01, Figure 1A).
|
The Effect of RA on Collagen Degradation
To determine if RA altered collagen degradation, hydroxyproline content within the gels was determined. Over the five-day culture period, NE and cytomix added together resulted in nearly complete degradation of the collagen within the gel (Figure 1B). RA had no effect on collagen degradation when added either alone or in the presence of cytomix or NE. However, RA dramatically reduced the synergistic degradation that occurred in the presence of NE and cytomix together (7.3 ± 0.4 versus 17.9 ± 1.4 µg/gel).
To determine if RA inhibited collagen degradation in a concentration-dependent manner, various concentrations of RA were added to fibroblast cultures containing both NE and cytomix. In the presence of this combination without RA, 98% of the collagen was degraded. Over the concentration range 0.01 µM to 1 µM, RA demonstrated a concentration-dependent inhibition of collagen degradation (Figure 2).
|
Effect of RA Inhibition of Collagen Degradation Induced
by NE in Combination with TNF-
, IL-1
, or IFN-
To determine if RA was affecting an interaction of any one
component of cytomix with NE, each component was added
to fibroblast gel cultures alone and in combination with NE
in the presence and absence of RA. As shown in Table 1, individual components resulted in minimal degradation of collagen contained in the floating gels. NE resulted in increased
degradation of collagen in the presence of TNF-
(P < 0.01)
and in a smaller but significant augmentation of degradation
in the presence of IL-1
(P < 0.05). NE added with IFN-
was not significantly different with regard to collagen degradation than NE alone. NE added with the individual cytokines, however, was not as effective in leading to collagen degradation as was the combination with cytomix (Figure 1B
and Table 1). The addition of RA resulted in an attenuation
of collagen degradation which was most marked for the
combination of RA and TNF-
(Table 1).
|
Effect of RA on NE Activity
To determine if RA resulted in direct inhibition of NE activity, cultures were prepared with and without fibroblasts
and incubated with NE, cytomix, or their combination in
the presence and absence of RA. As a control, the NE inhibitor
1 protease inhibitor (
1-PI) was applied. In the
presence of
1-PI, no NE activity was detected at any time
(data not shown). At 2 h, RA had no effect on NE activity in gels containing fibroblasts or in the absence of cells
(Figures 3A and 3B). Interestingly, a dramatic decrease occurred in NE activity over 12 h of culture, perhaps due to
autodegradation of the NE. In the absence of fibroblasts,
this resulted in complete loss of NE activity over 12 h (Figure 3B). In the presence of fibroblasts, however, residual
elastase activity was detectable throughout the culture
(Figure 3A). At 12 h, only 3.9 ± 4.4% of the initial elastase
activity was observed, after which elastase-like activity
gradually increased with culture time. By 48 h, it increased to 28.7 ± 1.5% of initial activity. RA inhibited elastase-like activity significantly only at 48 h (15.9 ± 2.6% of the
initial activity, P < 0.05). Cytomix added with elastase (Figure 3C) resulted in more elastase-like activity than elastase
alone (Figure 3A). This was significantly inhibited by RA
(Figure 3C, 25.8 ± 1.2% versus 18.8 ± 1.4% of initial elastase
activity at 48 h, P < 0.05).
|
Effect of RA on MMP-2 and MMP-9 Activity: Gelatin Zymography
Gelatinases released by fibroblasts cultured in three-dimensional collagen gels were assessed by gelatin zymography (Figure 4). Under control conditions, fibroblasts released primarily MMP-2 (gelatinase A) into surrounding medium as identified by its characteristic molecular weight of 72 kD (latent form) and 66 kD (active form). This identification was confirmed by Western blotting (data not shown). Exposure to NE appeared to increase the amount of MMP-2 and to increase the percentage present in the active form (Figure 5A). RA did not markedly affect MMP-2 under either control conditions or in the presence of NE (Figure 4A).
|
|
In the presence of cytomix, a marked induction MMP-9 (gelatinase B) was identified by its characteristic molecular weight of 92 kD (Figure 4B) and confirmed by Western blotting (data not shown). Retinoic acid increased the amount of detectable latent MMP-9 (Figure 4B). Within the detectable limits of zymography, exposure to NE resulted in complete conversion of latent MMP-9 to the active 83 kD form in the presence of cytomix alone. When RA and NE were present together, however, there was only partial conversion of MMP-9 from the 92 kD to the 83 kD form (Figure 4B).
The individual cytokines contained in the cytomix were
also evaluated. Both TNF-
and IL-1
increased the amount
of latent MMP-9 release, while IFN-
had no detectable
effect (Figure 4C). RA increased the apparent amount of
MMP-9 induced in the presence of cytokines, and exposure to NE resulted in partial conversion to lower molecular weight forms corresponding to active MMP-9. This
conversion was only partial and, in this respect, differed from the complete conversion that occurred with NE in
the presence of cytomix. RA reduced the amount of detectable MMP-9 when NE was added to individual cytokines (Figure 4C).
Effect of RA on Induction of MMP-1 Expression and Activation
Immunoblotting was performed to determine the effect of RA on MMP-1 (Figure 5). Under control conditions, a small amount of MMP-1 was detectable with an apparent molecular size of 52 kD, corresponding to the latent form of MMP-1 (Figure 5A). Minimal MMP-1 was detectable under control conditions or with RA. Neutrophil elastase alone induced MMP-1. RA reduced the detectable MMP-1 in the presence of NE (Figure 5A).
In the presence of cytomix, a marked induction of MMP-1 release was observed (Figure 5B). RA reduced the MMP-1 production induced by cytomix. Co-exposure to NE, however, subsequently converted some of the MMP-1 to lower molecular weight forms corresponding to 42 kD and 20 kD, consistent with the size expected for active MMP-1. RA added with NE reduced the amount of MMP-1 detectable in both higher and lower molecular weight forms (Figure 5B).
The individual cytokines were less potent than cytomix
in induction of MMP-1. TNF-
was more effective than
IL-1
, while IFN-
appeared to have a minor effect on
MMP-1 induction. RA appeared to attenuate the TNF-
and IL-1
induction of MMP-1. Exposure to NE resulted
in the conversion of MMP-1 to lower molecular weight forms corresponding to active MMP-1. RA added with NE
appeared to reduce the amount of active MMP-1 in the
presence of TNF-
or IL-1
(Figure 5C).
Effect of RA on MMP-3
Immunoblotting was performed to determine the effect of RA on MMP-3 (Figure 6). Fibroblasts incubated without cytokines produced no detectable MMP-3, and neither the presence of NE nor RA altered this (Figure 6A). In the presence of cytomix, however, detectable MMP-3 was observed with an apparent molecular size of both 57 kD, and smaller amounts were detectable in lower molecular weight forms (Figure 6B). Co-exposure to NE resulted in increased amount of MMP-3 detectable in lower molecular weight forms (Figure 6B). RA reduced the cytomix induction of both latent and active forms of MMP-3.
|
Both IL-1
and TNF-
were able to induce the release
of detectable MMP-3 with IL-1
being considerably more
effective than TNF-
(Figure 6C). Interferon-
alone did
not induce the release of MMP-3. Increased amount in
MMP-3 to lower molecular weight forms was observed
when NE was added in the presence of IL-1
, and this was
reduced in the presence of RA. RA also appeared to reduce the amount of MMP-3 detectable in the latent form
when added to TNF-
or IL-1
in the presence of NE, an
effect that was also observed in the presence of cytomix.
Effect of RA on TIMP-1 and TIMP-2
As MMP activity can be regulated by the presence of inhibitors, prominently TIMPs, the effect of RA on release of TIMP-1 and TIMP-2 was investigated by immunoblotting (Figure 7). Detectable TIMP-1 was released from fibroblasts cultured in three-dimensional collagen gels under control conditions. Bands were detectable both at 30 kD corresponding to free TIMP-1 and to higher molecular weight forms consistent with TIMP-1 complexed with MMPs. RA resulted in a reduction in the amount of TIMP-1 detectable in higher molecular weight forms. NE reduced the amount of free TIMP-1 while RA added together with NE appeared to increase free TIMP-1 as well as increase the amount of TIMP-1 present in higher molecular weight forms (Figure 7A).
|
Cytomix resulted in significant induction of TIMP-1 release. The amount of detectable TIMP-1 was reduced in the presence of NE while RA increased it (Figure 7B).
In contrast to TIMP-1, no detectable TIMP-2 was recovered under control conditions (Figure 7C). In the presence of cytomix, however, TIMP-2 could be readily detected migrating with a molecular size corresponding to 72 kD (Figure 7D). RA reduced this band, and exposure to NE nearly completely eliminated it.
| |
Discussion |
|---|
|
|
|---|
The current study demonstrates that RA can modulate the
degradation of type I collagen by fibroblasts cultured in three-dimensional gels. In the presence of cytokines, which induce matrix metalloproteinase production, and NE, which
results in activation of latent MMPs, nearly complete degradation of extracellular type I collagen can occur. RA can
inhibit this degradation in a concentration-dependent manner. The effect of RA was observed with TNF-
and IL-1
separately and when combined with IFN-
together as cytomix (18). The degradation of collagen was associated with
augmented fibroblast-mediated contraction of the three-dimensional collagen gels, and this was also inhibited by
RA. RA did not appear to inhibit NE directly but did result in inhibition of MMP activation. Taken together, the
results of the current study support the concept that RA
can modulate tissue remodeling by altering cytokine-driven
tissue degradation.
RA is a multi-functional hormone capable of modulating a variety of developmental and inflammatory processes (5, 12, 13). In the lung, RA is believed to play a pivotal role in the formation of alveolar structures (4). At the time of alveolarization, lung fibroblasts contain large quantities of RA (24), and retinoid receptors are expressed within the lung at high levels (25). Exogenous administration of retinoids can accelerate alveolarization in neonatal animals (4).
Destruction of alveoli is the characteristic and defining
feature of pulmonary emphysema (2). The observation
that individuals with a homozygous deficiency of
1 protease inhibitor are at increased risk for the development of
emphysema led to the "protease anti-protease" hypothesis
of emphysema (2). This model, now greatly expanded, suggests that the unopposed action of proteases, oxidants
and possibly other destructive moieties cause tissue destruction in emphysema (9, 10). Cigarette smoke may lead
to emphysema by initiating inflammatory responses thus
inducing the production of proteases and other destructive
factors (26). In addition, cigarette smoke may deplete anti-protease and anti-oxidant defenses (27, 28).
The specific proteolytic enzymes responsible for the development of emphysema are not entirely defined. Animal
models with exogenous protease administration suggests
that enzymes with elastolytic activity are required (7). NE
and other serine proteases that can be inhibited by
1 protease inhibitor, have been suggested to play an important
role (2). Studies with genetically manipulated mice, however, have established a role for matrix metalloproteinases, in particular MMP-12, an elastolytic enzyme derived
from macrophages (29). Evidence has also developed that
collagenase may contribute to the development of emphysema (30). Roles for these various proteases are not exclusive. Not only can they synergize with regard to degradation of extracellular matrix, but various proteases can
augment each other's activities by several mechanisms. In this context, some proteases are released as latent precursors that can be activated through the proteolytic action of
other proteases. In addition, proteolytic cleavage of anti-proteases can remove inhibitory mechanisms. The current
study is consistent with a collaborative interaction among
proteases leading to tissue destruction (11, 31).
The "classical" concept that once developed
that emphysema is irreversible
has been challenged by recent
animal studies (3). Using the well-described model of porcine pancreatic elastase-induced emphysema in the rat,
Massaro and Massaro demonstrated that the administration of retinoids can induce neoalveolarization with partial
reversal of the emphysema. A recapitulation of the developmental processes regulated by retinoids has been suggested as a mechanism for this effect. The current study
suggests that retinoids may be able to alter the development of emphysema by altering tissue destruction as well.
As noted above, transgenic mice that over-express collagenase developed emphysema, osteoarthritis and delay of
epidermal wound healing (33). In this context, macrophages, as well as mesenchymal cell production of MMP-1,
are known to contribute to tissue destruction in a variety of
settings, including emphysema, osteoarthritis, osteoporosis, ulcers and tumor invasion (33, 35). It seems likely
that normal lung structure maintenance requires ongoing
tissue deposition and removal. That retinoids may be able
to modulate this process, both by regulating alveolarization and by regulating tissue destruction, is consistent with
coordinated regulation of these processes.
The current system utilized the in vitro model system of fibroblasts cultured in three-dimensional collagen gels. This culture system has been suggested to more closely model in vivo tissues than routine culture on plastic dishes (39). Fibroblasts cultured in the three-dimensional matrix align themselves on the collagen fibers and have altered synthetic and functional activities. The ability of fibroblasts to contract extracellular matrix has been used as a model for both tissue repair and the development of contracted fibrotic scars (39, 40). Cytomix is able to inhibit fibroblast-mediated collagen gel contraction (41). This process is mediated by induction of fibroblast production of PGE2 and nitric oxide, which in turn inhibit gel contraction in a paracrine manner. In the absence of other stimuli, however, cytomix alone does not result in degradation of extracellular matrix.
When cultured in three-dimensional gels, fibroblasts are
also able to secrete metalloproteinases. The production of
matrix-degrading enzymes, including MMPs by fibroblasts,
is under cytokine control. In the current study, IL-1
and
TNF-
administered individually and in combination with
IFN-
were able to augment the production of several matrix-degrading enzymes. Degradation of the extracellular collagenous matrix, however, was minimal, presumably because the matrix metalloproteinases were largely secreted
in their latent form. In the presence of NE, however, conversion of the MMPs to active forms was documented although it is possible that the effect of elastase is indirect.
Concurrently, degradation of the extracellular matrix took
place. These results are consistent with a collaborative interaction among proteases leading to tissue destruction (11, 31).
RA was able to block the degradation of extracellular collagen caused by fibroblasts exposed to cytokines in the presence of NE. This inhibitory activity of RA was associated with a decrease in the activation of MMPs. These results suggest that RA, in addition to inducing anabolic effects, can also modulate the proteolytic activities likely present in an inflammatory milieu. This inhibitory activity of RA was not due to a direct effect on NE. Inhibition of the production of MMP-1 and/or -3 may account for the action of RA. The initial decline in elastase activity observed in fibroblast cultures and in cell-free gels is consistent with auto-degradation of the elastase. The subsequent increase in elastase activity in fibroblast cultures is consistent with production of amidolytic activity not directly identified in the current study. RA appeared to decrease the production of this activity as well. As RA is able to affect multiple MMPs, however, it seems likely that retinoids may be acting at several steps in a proteolytic cascade, which ultimately leads to degradation of collagen.
The model system used in the current assay involves embedding fibroblasts in fibers composed of reconstituted type I collagen in a native confirmation. In vivo extracellular matrices are more complex and contain a variety of matrix components in addition to collagen. In addition to modulating the degradation of collagen, the current study suggests that retinoids, by altering proteolytic activities released by fibroblasts, are likely able also to modulate the degradation and turnover of connective tissue matrix components. As tissue development likely involves turnover and remodeling of extracellular matrix, the ability of retinoids to modulate matrix degradation may be closely connected to their effects on tissue development and repair.
The observation that retinoids have the potential for reversing emphysema raises exciting new possibilities for the treatment of a devastating disease previously thought to be irreversible. The mechanisms by which retinoids may alter emphysematous tissues remain to be fully defined. The current study suggests that in addition to stimulating anabolic effects, retinoids may modulate proteolytic processes including those thought to contribute to tissue destruction in emphysema.
| |
Footnotes |
|---|
Address correspondence to: Stephen I. Rennard, M.D., University of Nebraska Medical Center, 985125 Nebraska Medical Center, Omaha, NE 68198-5125. E-mail: srennard{at}unmc.edu
Abbreviations: Dulbecco's modified Eagle's medium, DMEM; fetal calf serum, FCS; interferon, IFN; interleukin, IL; matrix metalloproteinase, MMP; neutrophil elastase, NE; phosphate-buffered saline, PBS; retinoic acid, RA; tumor necrosis factor, TNF.| |
References |
|---|
|
|
|---|
1. Fujita, J., N. L. Nelson, D. M. Daughton, C. A. Dobry, J. R. Spurzem, S. Irino, and S. I. Rennard. 1990. Evaluation of elastase and antielastase balance in patients with bronchitis and pulmonary emphysema. Am. Rev. Respir. Dis. 142: 57-62 [Medline].
2.
Thurlbeck, W. M., and
N. L. Muller.
1994.
Emphysema: definition, imaging,
and quantification.
AJR.
163:
1017-1025
3. Massaro, G. D., and D. Massaro. 1997. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat. Med. 3: 675-677 [Medline].
4. Massaro, G. D., and D. Massaro. 1996. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am. J. Physiol. 270: L305-L3l0.
5.
Nabeyrat, E.,
V. Besnard,
S. Corroyer,
V. Cazals, and
A. Clement.
1998.
Retinoic acid-induced proliferation of lung alveolar epithelial cells: relation with the IGF system.
Am. J. Physiol.
275:
L71-L79
6. Laurell, C. B., and S. Eriksson. 1963. The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 15: 132-140 .
7. Crystal, R. G.. 1990. Beta 1-antitrypsin deficiency, emphysema, and liver disease. J. Clin. Invest. 85: 1343-1352 .
8. Ericksson, S.. 1964. Pulmonary emphysema and alpha-1 antitrypsin deficiency. Acta Med. Scand. 175: 197-205 [Medline].
9. Rahman, I., and W. MacNee. 1996. Role of oxidants/antioxidants in smoking induced lung disease. Free Radic. Biol. Med. 21: 669-681 [Medline].
10. Warren, J. S., K. J. Johnson, and P. A. Ward. 1991. Consequences of oxidant injury. In The Lung: Scientific Foundations. R. G. Crystal, J. B. West, et al., editors. Raven Press, Ltd., New York. 1829-1838.
11. Tetley, T. D.. 1997. Matrix metalloproteinases: a role in emphysema? Thorax 52: 495 [Medline].
12. Manna, B., M. Lund, P. Ashbaugh, B. Kaufman, and S. N. Bhattacharyya. 1994. Effect of retinoic acid on mucin gene expression in rat airways in vitro. Biochem. J. 297: 309-313 .
13. Gitter, B. D., and E. M. Koehneke. 1991. Retinoic acid potentiates interleukin-1- and fibroblast growth factor-induced human synovial fibroblast proliferation. Clin. Immunol. Immunopathol. 61: 191-201 [Medline].
14.
Anderson, I. C.,
D. J. Sugarbaker,
R. K. Ganju,
D. G. Tsarwhas,
W. G. Richards,
M. Sunday,
L. Kobzik, and
M. A. Shipp.
1995.
Stromelysin-3 overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts.
Cancer Res.
55:
4120-4126
15. Schroen, D. J., and C. E. Brinckerhoff. 1996. Inhibition of rabbit collagenase (matrix metalloproteinase-1, MMP-1) transcription by retionid receptors: evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun. J. Cell. Physiol. 169: 320-332 [Medline].
16.
Elsdale, T., and
J. Bard.
1972.
Collagen substrata for studies on cell behavior.
J. Cell Biol.
54:
626-637
17. Mio, T., Y. Adachi, D. J. Romberger, R. F. Ertl, and S. I. Rennard. 1996. Regulation of fibroblast proliferation in three dimensional collagen gel matrix. In Vitro Cell Dev. Biol. 32: 427-433 .
18.
Gutierrez, H.,
B. R. Pitt,
M. Schwarz,
S. C. Watkins,
C. Lowenstein,
I. Canniggia,
P. Cumley, and
B. A. Freeman.
1995.
Pulmonary alveolar epithelial
inducible NO synthase gene expression: regulation by inflammatory mediators.
Am. J. Physiol.
268:
L501-L508
19. Bergman, I., and R. Loxley. 1963. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal. Chem. 35: 1961-1965 .
20. Edwards, C. A., and W. D. O'Brien. 1980. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin. Chim. Acta. 104: 161-167 [Medline].
21.
Zhang, Y.,
K. McCluskey,
K. Fujii, and
L. M. Wahl.
1998.
Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by
TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms.
J. Immunol.
161:
3071-3076
22. Kleiner, D. E., and W. G. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218: 325-329 [Medline].
23. Bieth, J., B. Speiss, and C. G. Wermuth. 1974. The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem. Med. 11: 350-357 [Medline].
24. Massaro, D., and G. D. Massaro. 1986. Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition. Am. J. Physiol. 251: R218-R224 .
25.
Chytil, F., and
D. E. Ong.
1976.
Changes in levels of cellular retinol and retinoic acid binding proteins of liver and lung during perinatal development
of rat.
Proc. Natl. Acad. Sci. USA
73:
3976-3978
26. Tetley, T. D., S. F. Smith, G. H. Burton, A. J. Winning, N. T. Cooke, and A. Guz. 1987. Effects of cigarette smoking and drugs on respiratory tract proteases and antiproteases. Eur. J. Respir. Dis. 71: 93-102 [Medline].
27. Smith, S. F., A. Guz, N. T. Cooke, A. J. Winning, J. Foxall, and T. D. Tetley. 1986. Effects of cigarette smoke on antiproteases at the human lung surface. Eur. J. Respir. Dis. 69: 139-143 .
28. Hubbard, R. C., F. Ogushi, G. A. Fells, A. M. Cantin, S. Jallat, M. Courtney, and R. G. Crystal. 1987. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha-1 antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Invest. 80: 1289-1295 .
29.
Hautamaki, R. D.,
D. K. Kobayashi,
R. M. Senior, and
S. D. Shapiro.
1997.
Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.
Science
277:
2002-2004
30.
Dalal, S.,
K. Imai,
B. Mercer,
Y. Okada,
K. Chada, and
J. M. D'Armiento.
2000.
A role for collagenase (matrix metalloproteinase-1) in pulmonary
emphysema.
Chest
117:
227S-228S
31. Finlay, G. A., K. J. Russell, K. J. McMahon, E. M. D'arcy, J. B. Masterson, M. X. FitzGerald, and C. M. O'Connor. 1997. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52: 502-506 [Abstract].
32. D'Armiento, J., S. S. Dalal, Y. Okada, R. A. Berg, and K. Chada. 1992. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71: 955-961 [Medline].
33. Neuhold, L. A., L. Killar, W. Zhao, M. L. Sung, L. Warner, J. Kulik, J. Turner, W. Wu, C. Billinghurst, M. T., A. R. Poole, P. Babij, and L. J. DeGennaro. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107:35-44.
34. Di-Colandrea, T., L. Wang, J. Wille, J. D'Armiento, and K. K. Chada. 1998. Epidermal expression of collagenase delays wound-healing in transgenic mice. J. Invest. Dermatol. 111: 1029-1033 [Medline].
35. Shapiro, S. D.. 1997. Mighty mice: transgenic technology `knocks out' questions of matrix metalloproteinase function. Matrix Biol. 15: 527-533 [Medline].
36. Yokoyama, T., Y. Otani, N. Kurihara, Y. Sakurai, K. Kameyama, H. Suzuki, N. Igarashi, M. Kimata, N. Wada, T. Kubota, K. Kumai, and M. Kitajima. 2000. Matrix metalloproteinase expression in cultured human gastric wall fibroblasts: interactions with Helicobacter pylori isolated from patients with ulcers. Aliment-Pharmacol. Ther. 14: 1193-1198 .
37. Breckon, J. J., S. Papaiannou, L. W. Kon, A. Tumber, R. M. Hembry, G. Murphy, J. J. Reynolds, and M. C. Meikle. 1999. Stromelysin (MMP-3) synthesis is up-regulated in estrogen-deficient mouse osteoblasts in vivo and in vitro. J. Bone Miner Res. 14: 1880-1890 [Medline].
38. Giannelle, G., C. Bergamini, E. Fransvea, F. Marinosci, V. Quaranta, and S. Antonaci. 2001. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinase activity for migration and invasion. Lab. Invest. 81: 613-627 [Medline].
39.
Bell, E.,
B. Ivarsson, and
C. Merrill.
1979.
Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different
proliferative potential in vitro.
Proc. Natl. Acad. Sci. USA
76:
1274-1278
40.
Grinnell, F..
1994.
Fibroblasts, myofibroblasts and wound contraction.
J. Cell
Biol.
124:
401-404
41. Zhu, Y. K., X.-D. Liu, C. M. Skold, T. Umino, H. Wang, D. J. Romberger, J. R. Spurzem, T. Kohyama, F. Q. Wen, and S. I. Rennard. 2001. Inhibition of fibroblast-induced gel contraction is mediated by PGE2 and NO acting through separate parallel pathways. Am. J. Respir. Cell Mol. Biol. (In press).
This article has been cited by other articles:
![]() |
P. R. Reynolds, S. D. Kasteler, M. G. Cosio, A. Sturrock, T. Huecksteadt, and J. R. Hoidal RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1094 - L1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Reynolds, M. G. Cosio, and J. R. Hoidal Cigarette Smoke-Induced Egr-1 Upregulates Proinflammatory Cytokines in Pulmonary Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2006; 35(3): 314 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ning, C.-J. Li, N. Kaminski, C. A. Feghali-Bostwick, S. M. Alber, Y. P. Di, S. L. Otterbein, R. Song, S. Hayashi, Z. Zhou, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease PNAS, October 12, 2004; 101(41): 14895 - 14900. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Mao, D. P. Tashkin, P. N. Belloni, I. Baileyhealy, F. Baratelli, and M. D. Roth All-trans Retinoic Acid Modulates the Balance of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients With Emphysema Chest, November 1, 2003; 124(5): 1724 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Massaro and G. D. C. Massaro Retinoids, Alveolus Formation, and Alveolar Deficiency: Clinical Implications Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 271 - 274. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |